Evidence map›Paper›PMID 38634141›Full record

ArticleHaematologica2024

Outcome of infants with acute lymphoblastic leukemia treated with the Chinese Children's Cancer Group Acute Lymphoblastic Leukemia 2015 study protocol.

Alex W K Leung, Jiaoyang Cai, Zhi Wan, Jiefen Qin, Yongjun Fang, Lirong Sun, Jiashi Zhu, Shaoyan Hu, Ningling Wang, Pan Gao and 15 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Haematologica, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Alex W K LeungDepartment of Pediatrics, Hong Kong Children's Hospital, The Chinese University of Hong Kong, Hong Kong SAR.
Jiaoyang CaiDepartment of Hematology/Oncology, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, Key Laboratory of Pediatric Hematology and Oncology of China Ministry of Health, and National Children's Medical Center, Shanghai.
Zhi WanDepartment of Pediatrics, West China Second University Hospital, Sichuan University, Key Laboratory of Birth Defects and Related Disease of Women and Children, Ministry of Education, Chengdu.
Jiefen QinDepartment of Hematology/Oncology, Chongqing Medical University Affiliated Children's Hospital, Chongqing.
Yongjun FangDepartment of Hematology/Oncology, Children's Hospital of Nanjing Medical University, Nanjing.
Lirong SunDepartment of Pediatrics, Affiliated Hospital of Qingdao University, Qingdao.
Jiashi ZhuDepartment of Hematology/Oncology, Shanghai Children's Hospital, Shanghai.
Shaoyan HuDepartment of Hematology/Oncology, Children's Hospital of Soochow University, Suzhou.
Ningling WangDepartment of Pediatrics, Anhui Medical University Second Affiliated Hospital, Anhui.
Pan GaoDepartment of Hematology/Oncology, Xi 'an Northwest Women's and Children's Hospital, Xi 'an.
Xin TianDepartment of Hematology/Oncology, KunMing Children's Hospital, Kunming.
Xiaofan ZhuDepartment of Pediatrics, State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin.
Fen ZhouDepartment of Pediatrics, Union Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan.
Xuedong WuDepartment of Pediatrics, Nanfang Hospital, Southern Medical University, Guangzhou.
Xiuli JuDepartment of Pediatrics, Qilu Hospital of Shandong University, Jinan.
Xiaowen ZhaiDepartment of Hematology/Oncology, Children's Hospital of Fudan University, Shanghai.
Hua JiangDepartment of Hematology/Oncology, Guangzhou Women and Children's Medical Center, Guangzhou.
Qun HuDepartment of Pediatrics, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan.
Changda LiangDepartment of Hematology/Oncology, Jiangxi Provincial Children's Hospital, Nanchang.
Liangchun YangDepartment of Pediatrics, Xiangya Hospital Central South University, Changsha.
Hui ZhangDepartment of Hematology/Oncology, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, Key Laboratory of Pediatric Hematology and Oncology of China Ministry of Health, and National Children's Medical Center, Shanghai.
Jingyan TangDepartment of Hematology/Oncology, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, Key Laboratory of Pediatric Hematology and Oncology of China Ministry of Health, and National Children's Medical Center, Shanghai.
Ju GaoDepartment of Pediatrics, West China Second University Hospital, Sichuan University, Key Laboratory of Birth Defects and Related Disease of Women and Children, Ministry of Education, Chengdu.
Ching-Hon PuiDepartments of Oncology, Pathology, and Global Pediatric Medicine, St. Jude Children's Research Hospital, Memphis, Tennessee.
Chi-Kong LiDepartment of Pediatrics, Hong Kong Children's Hospital, The Chinese University of Hong Kong, Hong Kong SAR. ckli@cuhk.edu.hk.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antineoplastic Combined Chemotherapy ProtocolsPrecursor Cell Lymphoblastic Leukemia-LymphomaChinaEast Asian PeopleFemaleHumansInfantMaleTreatment Outcome

Identifiers

PMID38634141
PMCPMC11290514

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.